Autres langues Zhejiang Orient Gene Biotech Co.,Ltd

Actions

688298

CNE100003RM8

Cours en clôture Shanghai S.E. Autres places de cotation 00:00:00 13/05/2024			Varia. 5j.	Varia. 1 janv.
32,49 ^CNY	-5,28%		+9,91%	-9,14%

29/04	Zhejiang Orient Gene Biotech Co, Ltd publie ses résultats pour le premier trimestre clos le 31 mars 2024	CI
28/02	Zhejiang Orient Gene Biotech Co, Ltd publie ses résultats pour l'exercice clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Zhejiang Orient Gene Biotech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04
Zhejiang Orient Gene Biotech's Unit Gets US FDA's Nod to Register Two Products	23/04
Zhejiang Orient Gene Biotech Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	28/02
Zhejiang Orient Gene Biotech Co.,Ltd announces an Equity Buyback for CNY 100 million worth of its shares.	08/02
Zhejiang Orient Gene Biotech Co.,Ltd authorizes a Buyback Plan.	07/02
Zhejiang Orient Gene Obtains Veterinary GMP Certificate, Production License	08/01
Zhejiang Orient Gene Biotech Co.,Ltd(SHSE:688298) dropped from Shanghai Stock Exchange Health Care Sector Index	08/12
Zhejiang Orient Gene Biotech Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	30/10/23
Zhejiang Orient Gene Biotech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	29/08/23
Orient Gene Biotech Registers New In Vitro Diagnostic Reagents	13/07/23
Zhejiang Orient Gene Biotech Elects Chairman, Vice Chairman	01/06/23
Zhejiang Orient Gene Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	27/04/23
Zhejiang Orient Gene Registers Two Medical Devices in EU, US	24/03/23
Zhejiang Orient Gene Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	27/02/23
IN BRIEF: Omega Diagnostics receives CD4 deferred consideration	25/11/22
Zhejiang Orient Gene Biotech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	30/10/22
Zhejiang Orient Gene Biotech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	29/08/22
Omega Diagnostics Up 16% With Sale Of Loss-Making CD4 Business	03/08/22
ZXBio, Inc. announced that it has received $3.1 million in funding from Zhejiang Orient Gene Biotech Co., Ltd.	08/06/22
Zhejiang Orient Gene Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	27/04/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Zhejiang Orient Gene Biotech Co.,Ltd

Actions

688298

CNE100003RM8

Autres langues

Filtres